Learn about the clinical implications of rheumatoid factor positivity in psoriatic arthritis and its effect on biologic therapy discontinuation.
Morning Overview on MSN
Capivasertib won FDA approval for a hard-to-treat form of prostate cancer
Men diagnosed with metastatic prostate cancer that lacks the PTEN protein now have a targeted drug option for the first time.
Smart PSA boosted targeted screening and found more aggressive prostate cancers in Black men in Chicago trials.
Patients with advanced prostate cancer may need periodic imaging scans to catch tumor growth even with stable levels of ...
The Queen Zone on MSN
New blood test could help spot aggressive prostate cancer earlier
For many men, a prostate cancer scare starts with one number. A PSA result comes back high, and ...
A new 55mg prefilled syringe has been cleared to facilitate weight-based dosing for children weighing less than 40kg. The Food and Drug Administration (FDA) has expanded the approval of Skyrizi ® ...
A large analysis suggests that a multivariable risk assessment tool, called Stockholm3, can detect substantially more ...
A 74-year-old man with an active lifestyle and no family history of prostate cancer presented with mild urinary hesitancy and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results